Efficacy and safety of the administration of bevacizumab in combination with first-line chemotherapy for the treatment of advanced breast carcinoma: ATHENA MO19391 study results in Spanish patients

Ciruelos, E. M.; Lopez-Vivanco, G.; Pelaez, I.; Rifa, J.; Santaballa, A.; Gonzalez, S.; Segui, M. A.; Jara, C.; Alvarez, I.; Cortes-Funes, H.

doi:10.1186/bcr2307

Identifier to cite or link to this item: http://hdl.handle.net/20.500.13003/13746

View

000267618500047.pdf (427.6Kb)

Identifiers

URI: http://hdl.handle.net/20.500.13003/13746

DOI: 10.1186/bcr2307

ISSN: 1465-5411

WOS ID: 000267618500047

Embase PUI: L70338770

Metrics

Export

External links

Publication date

2009

Document type

contribution to journal

Citation

Ciruelos EM, Lopez-Vivanco G, Pelaez I, Rifa J, Santaballa A, Gonzalez S, et al. Efficacy and safety of the administration of bevacizumab in combination with first-line chemotherapy for the treatment of advanced breast carcinoma: ATHENA MO19391 study results in Spanish patients [meeting abstract]. Breast Cancer Res. 2009;11:S17-8.

Publisher version

https://dx.doi.org/10.1186/bcr2307

This item appears in following Docusalut collections

Hospital Universitario Son Espases - HUSE > Comunicación científica

This item's license is described as Attribution 4.0 International